Men And Women May Respond Differently to Latest Alzheimer’s Drugs
The latest drugs for Alzheimer’s disease may add years of independence to the lives of patients, but possibly only for some. A new analysis of clinical data suggests female brains may not respond to some of these novel medications as well as male brains.In an 18-month-long phase 3 clinical trial, the intravenous drug lecanemab slowed cognitive decline by as much as 27 percent compared […]
Men And Women May Respond Differently to Latest Alzheimer’s Drugs Read More »